Charles & Colvard Temettü

Temettü kriter kontrolleri 0/6

Charles & Colvard şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

Geri Alım Getirisi

Toplam Hissedar Getirisi	0%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Recent updates

Investors Don't See Light At End Of Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Tunnel

Sep 26

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) 26% Dip In Price Shows Sentiment Is Matching Revenues

Jun 12

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Business Is Yet to Catch Up With Its Share Price

Jan 23

Charles & Colvard Is Leading The Way In 'Made, Not Mined' Jewelry - High Return Potential

May 16

Silver Ring Value Partners - Charles & Colvard: Exited In Q4

Feb 22

Charles & Colvard (NASDAQ:CTHR) Is Doing The Right Things To Multiply Its Share Price

Dec 24

Charles & Colvard: While Diamonds Are A Girl's Best Friend, They Can Be An Investor's Best Bet

Dec 01

Charles & Colvard (NASDAQ:CTHR) Shareholders Will Want The ROCE Trajectory To Continue

Aug 26

Upgrade: Analysts Just Made A Sizeable Increase To Their Charles & Colvard, Ltd. (NASDAQ:CTHR) Forecasts

May 13

Charles & Colvard, Ltd. 2021 Q3 - Results - Earnings Call Presentation

May 08

We Like These Underlying Return On Capital Trends At Charles & Colvard (NASDAQ:CTHR)

Mar 31

Charles & Colvard, Ltd. Just Beat EPS By 200%: Here's What Analysts Think Will Happen Next

Feb 06

If You Had Bought Charles & Colvard (NASDAQ:CTHR) Stock Five Years Ago, You Could Pocket A 97% Gain Today

Jan 30

Insider Buying: The Charles & Colvard, Ltd. (NASDAQ:CTHR) Independent Director Just Bought 5.1% More Shares

Nov 20

Charles & Colvard Is A Growth ESG Company Trading Below Book

Nov 17

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: CTHR şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: CTHR şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Charles & Colvard Piyasaya Karşı Temettü Getirisi

CTHR temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (CTHR)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.5%
Sektör Ortalaması (Luxury)	2.0%
Analist tahmini (CTHR) (3 yıla kadar)	n/a

Önemli Temettü: CTHR şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, CTHR şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: CTHR şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: CTHR herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Charles & Colvard Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces an Equity Buyback for $5 million worth of its shares.

Recent updates

Charles & Colvard Receives Non-Compliance Letter from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1)

Charles & Colvard, Ltd. announced delayed annual 10-K filing

Investors Don't See Light At End Of Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Tunnel

New minor risk - Share price stability

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) 26% Dip In Price Shows Sentiment Is Matching Revenues

Charles & Colvard Approves 1-for-10 Reverse Split to Bring it into Compliance with Nasdaq's Minimum Bid Price Requirement for Continued Listing

Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.28 loss in 3Q 2023)

Charles & Colvard, Ltd. to Report Q3, 2024 Results on May 02, 2024

New minor risk - Share price stability

New major risk - Market cap size

Second quarter 2024 earnings released: US$0.094 loss per share (vs US$0.034 loss in 2Q 2023)

Charles & Colvard, Ltd. to Report Q2, 2024 Results on Feb 13, 2024

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Business Is Yet to Catch Up With Its Share Price

Insufficient new directors

Charles & Colvard Receives Notification Letter from Nasdaq Regarding Eligible for an Additional 180-Day Grace Period, or Until June 10, 2024 to Regain Compliance with the Minimum Bid Price Requirement

Charles & Colvard, Ltd. to Report Q1, 2024 Results on Nov 09, 2023

Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023

Charles & Colvard, Ltd. to Report Q4, 2023 Results on Oct 12, 2023

Charles & Colvard, Ltd. Provides Earnings Guidance for the Fiscal Year Ended June 30, 2023

Insufficient new directors

Charles & Colvard Receives Notification Letter from Nasdaq’s Listing Qualifications Department Indicating that the Company Is Not in Compliance with Nasdaq Listing Rule 5550(a)(2)

Insider recently bought US$204k worth of stock

Third quarter 2023 earnings released: US$0.28 loss per share (vs US$0.011 profit in 3Q 2022)

Insider recently bought US$1.6m worth of stock

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Charles & Colvard, Ltd. to Report Q2, 2023 Results on Feb 02, 2023

Charles & Colvard Receives A Notification Letter from Nasdaq Regarding Minimum Bid Price

Consensus EPS estimates fall by 200%

Consensus EPS estimates fall by 200%

First quarter 2023 earnings released: US$0.029 loss per share (vs US$0.028 profit in 1Q 2022)

Charles & Colvard, Ltd. to Report Q1, 2023 Results on Nov 03, 2022

Charles & Colvard Launches Lab Grown Precious Gemstones Giving Their Conscious Fine Jewelry Bold New Color

Charles & Colvard: Lab Grown Diamonds Can Survive A Recession

Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022

Charles & Colvard® Expands Signature Collection to Include All New Lab Grown Diamond Men's Bands

Consensus EPS estimates have been downgraded.

President exercised options and sold US$53k worth of stock

Investors Will Want Charles & Colvard's (NASDAQ:CTHR) Growth In ROCE To Persist

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Charles & Colvard Q4 2022 Earnings Preview

Charles & Colvard, Ltd. to Report Q4, 2022 Results on Sep 01, 2022

Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture Collection

Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture Collection

Charles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth Index

Independent Chairman recently bought US$103k worth of stock

Charles & Colvard Is Leading The Way In 'Made, Not Mined' Jewelry - High Return Potential

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces an Equity Buyback for $5 million worth of its shares.

Price target decreased to US$3.25

Charles & Colvard, Ltd. to Report Q3, 2022 Results on May 05, 2022

Silver Ring Value Partners - Charles & Colvard: Exited In Q4

Independent Chairman exercised options to buy US$89k worth of stock.

Consensus forecasts updated

Price target decreased to US$3.25

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Charles & Colvard (NASDAQ:CTHR) Is Doing The Right Things To Multiply Its Share Price

Independent Director exercised options to buy US$466k worth of stock.

Charles & Colvard: While Diamonds Are A Girl's Best Friend, They Can Be An Investor's Best Bet

First quarter 2022 earnings released: EPS US$0.028 (vs US$0.03 in 1Q 2021)

Independent Director exercised options to buy US$246k worth of stock.

Full year 2021 earnings released: EPS US$0.44 (vs US$0.21 loss in FY 2020)

Charles & Colvard (NASDAQ:CTHR) Shareholders Will Want The ROCE Trajectory To Continue

Independent Chairman exercised options to buy US$128k worth of stock.

Investor sentiment improved over the past week

Upgrade: Analysts Just Made A Sizeable Increase To Their Charles & Colvard, Ltd. (NASDAQ:CTHR) Forecasts

Charles & Colvard, Ltd. 2021 Q3 - Results - Earnings Call Presentation

We Like These Underlying Return On Capital Trends At Charles & Colvard (NASDAQ:CTHR)

Independent Chairman exercised options to buy US$175k worth of stock.

New 90-day high: US$2.80

Independent Director exercised options to buy US$135k worth of stock.

Independent Chairman exercised options to buy US$332k worth of stock.

New 90-day high: US$2.39

Second quarter 2021 earnings released: EPS US$0.087 (vs US$0.028 in 2Q 2020)

Revenue and earnings beat expectations